# Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)

> **NCT00793247** · PHASE2 · COMPLETED · sponsor: **Movetis**

## Conditions studied

- Chronic Intestinal Pseudo-Obstruction

## Interventions

- **DRUG:** PRU-PLA-PRU-PLA
- **DRUG:** PLA-PRU-PLA-PRU
- **DRUG:** PLA-PRU-PRU-PLA
- **DRUG:** PRU-PLA-PLA-PRU

## Key facts

- **NCT ID:** NCT00793247
- **Lead sponsor:** Movetis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793247, "Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00793247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*